Durability of Ruxolitinib for PV, Dr V in Target... - MPN Voice

MPN Voice

10,886 members15,202 posts

Durability of Ruxolitinib for PV, Dr V in Targeted Oncology interview

ainslie profile image
8 Replies

A few weeks ago there was some discussion on there was some discussion on her re the durability of Rux for PV. Below is a answer to that from Dr V in a interview with Targeted Oncolgy in Nov 2022

In polycythemia vera, ruxolitinib is valuable as a second-line choice when things don't go well with hydroxyurea. Patients then have much higher white blood cell counts, may have a big spleen, and of course, require phlebotomy. In that setting, it has been proven in 2 randomized studies that ruxolitinib provides a significant clinical benefit in normalizing blood cell count, improving quality of life, and decreasing spleen in those that have a big spleen. It appears after many years of follow-up that this is very durable, and possibly decreases the risk of early death from the complications of uncontrolled polycythemia vera. We use it often in the second-line setting, and it is a number 1 choice in PV.

Written by
ainslie profile image
ainslie
To view profiles and participate in discussions please or .
Read more about...
8 Replies
MCW22 profile image
MCW22

I was put on ruxolitinib after 2 years of hydroxy failed to bring my white count down. Initially it brought my whites down from 30 to 17 however after just over 2 years on it my whites are now mid to high 20s. All other counts are OK.

ainslie profile image
ainslie in reply toMCW22

what dose are you on and for how long, also what are your other counts in particular Hgb,Hct,platelets, are you venisecting

MCW22 profile image
MCW22 in reply toainslie

I take 2 x 5mg tablets in the morning and another 2 early evening. I expect to continue until told otherwise. My last results were

Wbc 29.2

Rbc 4.54

Hb 113

Hct 0.352

Mcv 78

Mch 25.0

Platelets 218

Neutrophils 22.19

Lymphocytes 1.46

Monocytes 1.75

Eosinophils 0.58

Basophils 2.34

Myelocytes 0.58

Blasts 0.29

Ferritin 45

Cholesterol 4.2

These are from 3 months ago as that is how often I've been having phone appointments. I had a blood test a couple of days ago but won't know the results until my next phone appointment in just over a week.

My consultants just seem to focus on hematocrit, platelets and Hb. They never commented on the white count, yet that is the one that worries me. I only ever had 4 venesections at diagnosis and before starting drugs. Hope this helps.

Carol

ainslie profile image
ainslie in reply toMCW22

how long have you been on Rux

ainslie profile image
ainslie in reply toMCW22

ah forgot, and what is your concern about whites

MCW22 profile image
MCW22

To my knowledge high whites can contribute to blood clots. Also it makes me wonder if I am progressing from PV to MF

ainslie profile image
ainslie in reply toMCW22

I used to have high whites on venisection only, around 25 and when I looked in to it, it seemed a grey area as to how much of additional thrombotic risk high whites are and perhaps more relevant I think it was a talk by Dr Machinares at a recent conference said that although high whites maybe a increased risk, lowering them didnt reduce that risk for some reason. I was going to say when was your last BMB and when did you start Rux, I noticed on Rux some counts are slow in coming down but can come down further over time, looking at your Hct and HGB there isnt much room to increase the dose. What does your haem have to say about it.

MCW22 profile image
MCW22

I've only had one BMB and it was after that they put me on ruxolitinib. I've been on the same dose since starting it and each appointment they say to continue on that dose. They seem happy with my numbers. I guess if they suggest a change in anything that would be the time to worry.

Not what you're looking for?

You may also like...

Combined ruxolitinib and pegasys therapy for MF and PV gives great results. Danish phase 2 study Jan 2020 ( ruxopeg)

Hi I’ve pasted in the abstract of the Danish ruxopeg study instead of just the link, as it’s such...

Ruxolitinib Provides Better Efficacy Than Best Available Therapy in Polycythemia Vera

« Patients with polycythemia vera (PV) achieved greater hematocrit control and improvement in...
Manouche profile image

BESREMi now recommended as a Preferred First-line Cytoreductive Therapy for PV in Updated NCCN Clinical Practice Guidelines in Oncology

 « The National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN...
Manouche profile image

SMC decision regarding Ruxolitinib (Jakavi) for PV patients in Scotland

We are very pleased to announce that following a full submission made to the SMC (Scottish...
Mazcd profile image
Partner

NICE Final Guidance on Ruxolitinib for the treatment of Polycythaemia Vera

We are delighted to announce that NICE (the National Institute for Health and Care Excellence) has...
Mazcd profile image
Partner

Moderation team

Debinha profile image
DebinhaAdministrator
Mazcd profile image
MazcdPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.